Kerry A. Chester

72 Huntley Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: April 28, 2026

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.

Journal: Immunity

Published: May 30, 2025

Phenoscaping Reveals Multimodal γδ T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell-Mediated Immunomodulation.

Phenoscaping Reveals Multimodal γδ T-cell Cytotoxicity as a Strategy to Overcome Cancer Cell-Mediated Immunomodulation.

Journal: Cancer research

Published: May 01, 2025

Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression.

Exploring targets in oropharyngeal cancer - association with immune markers and AI-scoring of B7-H3 expression.

Journal: Clinical and translational medicine

Published: December 10, 2024

Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma.

Payload-delivering engineered γδ T cells display enhanced cytotoxicity, persistence, and efficacy in preclinical models of osteosarcoma.

Journal: Science translational medicine

Published: May 29, 2024

Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function.

Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function.

Journal: Nature communications

Published: April 08, 2024

scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells.

scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells.

Journal: Journal of nanobiotechnology

Published: August 11, 2023

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: July 27, 2023

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.

Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies.

Journal: Immunity

Published: June 26, 2023

A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors.

A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors.

Journal: Cell death & disease

Published: October 06, 2022

Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library.

Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library.

Journal: Medical oncology (Northwood, London, England)

Published: June 07, 2022

A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers.

A novel anti-B7-H3 chimeric antigen receptor from a single-chain antibody library for immunotherapy of solid cancers.

Journal: Molecular therapy oncolytics

Published: April 14, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026